Literature DB >> 29442352

Guidelines of Polish National Societies Diagnostics and Treatment of Thyroid Carcinoma. 2018 Update.

Barbara Jarząb1, Marek Dedecjus, Dorota Słowińska-Klencka, Andrzej Lewiński, Zbigniew Adamczewski, Ryszard Anielski, Maciej Bagłaj, Agata Bałdys-Waligórska, Marcin Barczyński, Tomasz Bednarczuk, Artur Bossowski, Monika Buziak-Bereza, Ewa Chmielik, Andrzej Cichocki, Agnieszka Czarniecka, Rafał Czepczyński, Janusz Dzięcioł, Tomasz Gawlik, Daria Handkiewicz-Junak, Kornelia Hasse-Lazar, Alicja Hubalewska-Dydejczyk, Krystian Jażdżewski, Beata Jurecka-Lubieniecka, Michał Kalemba, Grzegorz Kamiński, Małgorzata Karbownik-Lewińska, Mariusz Klencki, Beata Kos-Kudła, Agnieszka Kotecka-Blicharz, Aldona Kowalska, Jolanta Krajewska, Aleksandra Kropińska, Aleksandra Kukulska, Emilia Kulik, Andrzej Kułakowski, Krzysztof Kuzdak, Dariusz Lange, Aleksandra Ledwon, Elżbieta Lewandowska-Jabłońska, Katarzyna Łącka, Barbara Michalik, Anna Nasierowska-Guttmejer, Janusz Nauman, Marek Niedziela, Ewa Małecka-Tendera, Małgorzata Oczko-Wojciechowska, Tomasz Olczyk, Ewa Paliczka-Cieślik, Lech Pomorski, Zbigniew Puch, Józef Roskosz, Marek Ruchała, Dagmara Rusinek, Stanisław Sporny, Agata Stanek-Widera, Zoran Stojcev, Aleksandra Syguła, Anhelli Syrenicz, Sylwia Szpak-Ulczok, Tomasz Tomkalski, Zbigniew Wygoda, Jan Włoch, Ewa Zembala-Nożyńska.   

Abstract

Significant advances have been made in thyroid can-cer research in recent years, therefore relevant clinical guidelines need to be updated. The current Polish guidelines "Diagnostics and Treatment of Thyroid Carcinoma" have been formulated at the "Thyroid Cancer and Other Malignancies of Endocrine Glands" conference held in Wisła in November 2015 [1].

Entities:  

Keywords:  anapaestic thyroid cancer; differentiated thyroid cancer; guidelines; medullary thyroid cancer; recommendations; thyroid cancer

Mesh：

Year:  2018        PMID： 29442352     DOI： 10.5603/EP.2018.0014

Source DB:  PubMed          Journal:  Endokrynol Pol        ISSN： 0423-104X            Impact factor:   1.582


  12 in total

1.  A Mathematical Model to Assess the Effect of Residual Positive Lymph Nodes on the Survival of Patients With Papillary Thyroid Microcarcinoma.

Authors:  Wen Liu; Xuejing Yan; Zhizhong Dong; Yanjun Su; Yunhai Ma; Jianming Zhang; Chang Diao; Jun Qian; Tao Ran; Ruochuan Cheng
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

2.  Hashimoto's Thyroiditis Does Not Influence the Malignancy Risk in Nodules of Category III in the Bethesda System.

Authors:  Dorota Słowińska-Klencka; Bożena Popowicz; Mariusz Klencki
Journal:  Cancers (Basel)       Date:  2022-04-13       Impact factor: 6.575

Review 3.  The active surveillance management approach for patients with low risk papillary thyroid microcarcinomas: is China ready?

Authors:  Wen Liu; Xuejing Yan; Ruochuan Cheng
Journal:  Cancer Biol Med       Date:  2021-09-24       Impact factor: 5.347

4.  Prospective analysis of inter-observer and intra-observer variability in multi ultrasound descriptor assessment of thyroid nodules.

Authors:  Katarzyna Dobruch-Sobczak; Bartosz Migda; Agnieszka Krauze; Krzysztof Mlosek; Rafał Z Słapa; Paweł Wareluk; Elwira Bakuła-Zalewska; Zbigniew Adamczewski; Andrzej Lewiński; Wiesław Jakubowski; Marek Dedecjus
Journal:  J Ultrason       Date:  2019-09-30

5.  Is it safe for patients to apply standardized malignancy risk stratification systems in the management of thyroid nodules?

Authors:  Zbigniew Adamczewski
Journal:  J Ultrason       Date:  2020-06-15

6.  The Presence of Hypoechoic Micronodules in Patients with Hashimoto's Thyroiditis Increases the Risk of an Alarming Cytological Outcome.

Authors:  Dorota Słowińska-Klencka; Martyna Wojtaszek-Nowicka; Mariusz Klencki; Kamila Wysocka-Konieczna; Bożena Popowicz
Journal:  J Clin Med       Date:  2021-02-07       Impact factor: 4.241

7.  Is eNAMPT/visfatin a potential serum marker of papillary thyroid cancer?

Authors:  Nadia Sawicka-Gutaj; Paulina Ziółkowska; Aleksandra Derwich; Paweł Gut; Agata Czarnywojtek; Michał Kloska; Marek Ruchała
Journal:  Ther Adv Endocrinol Metab       Date:  2022-04-13       Impact factor: 4.435

8.  Accuracy of the European Thyroid Imaging Reporting and Data System (EU-TIRADS) in the valuation of thyroid nodule malignancy in reference to the post-surgery histological results.

Authors:  Anna Skowrońska; Justyna Milczarek-Banach; Wiesław Wiechno; Witold Chudziński; Marcin Żach; Michał Mazurkiewicz; Piotr Miśkiewicz; Tomasz Bednarczuk
Journal:  Pol J Radiol       Date:  2018-12-19

9.  High incidence of FLT3 mutations in follicular thyroid cancer: potential therapeutic target in patients with advanced disease stage.

Authors:  Martyna Borowczyk; Ewelina Szczepanek-Parulska; Szymon Dębicki; Bartłomiej Budny; Małgorzata Janicka-Jedyńska; Lidia Gil; Frederik A Verburg; Dorota Filipowicz; Elżbieta Wrotkowska; Blanka Majchrzycka; Andrzej Marszałek; Katarzyna Ziemnicka; Marek Ruchała
Journal:  Ther Adv Med Oncol       Date:  2020-03-04       Impact factor: 8.168

10.  Only peak thyroglobulin concentration on day 1 and 3 of rhTSH-aided RAI adjuvant treatment has prognostic implications in differentiated thyroid cancer.

Authors:  Aleksandra Ledwon; Ewa Paliczka-Cieślik; Aleksandra Syguła; Tomasz Olczyk; Aleksandra Kropińska; Agnieszka Kotecka-Blicharz; Kornelia Hasse-Lazar; Aneta Kluczewska-Gałka; Barbara Jarząb; Daria Handkiewicz-Junak
Journal:  Ann Nucl Med       Date:  2021-08-07       Impact factor: 2.668
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.